Product Information
LEXAPRO 5 MG TABLET is a brand product labeled by Allergan, Inc., priced at $14.7432 per EA under NDC 00456200501. Its NADAC has been published 669 times since Nov 28, 2013.
FDA first approved this application on Aug 14, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ESCITALOPRAM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Allergan, Inc.NDC
00456200501
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/2/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
New Drug (NDA)
FDA Application
NDA021323FDA Approved
8/14/2002
TE Code
AB
On Market Since
8/14/2002
Pharmacological Classes
Price Statistics
The NADAC for LEXAPRO 5 MG TABLET has been published 669 times since Nov 28, 2013, and over the history we have for it it has risen 204.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.7432 per EA |
|---|---|
| All-time high | $14.7432 (Sep 30, 2026) |
| All-time low | $4.8405 (Nov 28, 2013) |
| 52-week high | $14.7432 |
| 52-week low | $14.0263 |
| Median price | $11.2408 |
| Average price | $10.6414 |
| Largest weekly change | +11.0% (Jul 8, 2015) |
| Weeks tracked | 669 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ESCITALOPRAM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ESCITALOPRAM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEXAPRO 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEXAPRO 5 MG TABLET, manufactured by Allergan, Inc., is $14.7432 per EA (NDC 00456200501), effective Sep 30, 2026.
How has the price of LEXAPRO 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEXAPRO 5 MG TABLET has risen 204.6%. It has been tracked across 669 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEXAPRO 5 MG TABLET?
Since Nov 28, 2013, the NADAC for LEXAPRO 5 MG TABLET has ranged from a low of $4.8405 (Nov 28, 2013) to a high of $14.7432 (Sep 30, 2026), with a median of $11.2408 per EA.
Are there cheaper alternatives to LEXAPRO 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of LEXAPRO 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LEXAPRO 5 MG TABLET?
LEXAPRO 5 MG TABLET (NDC 00456200501) is labeled by Allergan, Inc., and CMS classifies it as a brand product.